Disposition of 10000 shares by Michael Klein of Travelers Companies at 126.18 subject to Rule 16b-3
ICAD Stock | USD 2.34 0.02 0.85% |
About 60% of Icad's investor base is looking to short. The analysis of the overall investor sentiment regarding icad inc suggests that many traders are alarmed. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
Icad |
Filed transaction by The Travelers Companies Officer: Evp & President, Personal Ins.. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Icad Fundamental Analysis
We analyze Icad's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Icad is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
icad inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Icad stock to make a market-neutral strategy. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics with similar companies.
Peers
Icad Related Equities
ESTA | Establishment Labs | 7.74 | ||||
LNSR | LENSAR | 3.78 | ||||
PROF | Profound Medical | 1.86 | ||||
SSKN | STRATA Skin | 1.52 | ||||
MOVE | Movano | 1.19 | ||||
NVNO | EnVVeno Medical | 0.67 | ||||
NVRO | Nevro Corp | 0.17 | ||||
FNA | Paragon 28 | 0.08 | ||||
SRDX | SurModics | 1.49 | ||||
SGHT | Sight Sciences | 1.59 | ||||
CVRX | CVRx | 2.11 | ||||
SIBN | Si Bone | 3.41 | ||||
AXGN | Axogen | 3.47 | ||||
BMRA | Biomerica | 4.23 | ||||
AIMD | Ainos | 7.55 |
Complementary Tools for Icad Stock analysis
When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |